Brief: Arctic Bioscience Says New Cellular Research Showing Anti-Psoriatic Effects
Sept 25 (Reuters) - Arctic Bioscience AS ABSA.OL :
* NEW CELLULAR RESEARCH SHOWING ANTI-PSORIATIC EFFECTS
* DATA CONTRIBUTE TO UNDERSTANDING OF HOW INVESTIGATIONAL
MEDICINAL PRODUCT HRO350 COULD IMPACT PSORIASIS
Source text for Eikon: ID:nWkr4vsc36
Further company coverage: ABSA.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Arctic Bioscience AS
See all newsNorway's Arctic Bioscience Q1 sales rise 78% to record on America boost
Brief: Arctic Bioscience Q1 Adjusted EBITDA NOK -6.5 Million
Norway's Arctic Bioscience 2025 revenue falls due to product recall impact
Brief: Arctic Bioscience Q3 Adjusted EBITDA NOK -7.8 Million
Brief: Arctic Bioscience H1 Adjusted EBITDA NOK -13.6 Million